Evidence map›Paper›PMID 39557732›Full record

ArticleEuropean journal of pediatrics2024

Persistent pulmonary hypertension in children after apparent resolution of ultrasound-defined pulmonary hypertension associated with bronchopulmonary dysplasia.

Mami Takeoka, Hirofumi Sawada, Yoshihide Mitani, Hiroyuki Ohashi, Noriko Yodoya, Kazunobu Ohya, Naoki Tsuboya, Tomoya Harada, Masahiro Hirayama

Abstract read
In one paragraph

Article in European journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mami TakeokaDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.
Hirofumi SawadaDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan. hisawada@med.mie-u.ac.jp.ORCID http://orcid.org/0000-0001-8069-5751
Yoshihide MitaniDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan. ymitani@med.mie-u.ac.jp.
Hiroyuki OhashiDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.
Noriko YodoyaDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.
Kazunobu OhyaDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.
Naoki TsuboyaDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.
Tomoya HaradaDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.
Masahiro HirayamaDepartment of Pediatrics, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu Mie, 514-8507, Japan.

Funding

A grant from Mie Prefecture Neonatal-Perinatal Medicine training project 2024
6 · The paper itself

Abstract

To evaluate pulmonary hemodynamics in patients who had been followed up for bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) in the mid-term by right heart catheterization (RHC). A retrospective study was conducted among 56 patients who were born at a gestational age < 28 weeks during 2018-2020, and the consecutive patients complicated by BPD and ultrasound-defined PH (n = 10, 18%), of whom 7 patients were treated with sildenafil, were examined by RHC in the mid-term follow-up (median age: 25 months [IQR: 19-32]). Ultrasound study at RHC showed improvement in PH as represented by left ventricular end-systolic eccentricity index (median [IQR], 1.05 [IQR: 1.03-1.06] vs. 1.18 [IQR: 1.15-1.33]), pulmonary artery acceleration time (PAAT) (mean ± SD, 97.3 ± 18.2 vs. 55.2 ± 10.1) and a ratio of PAAT to right ventricular ejection time (0.35 ± 0.05 vs. 0.25 ± 0.04) compared with those at 40 weeks of postmenstrual age (PMA) (p < 0.05, respectively). RHC (mean pulmonary artery [PA] pressure: 21 [19-22] mmHg; pulmonary vascular resistance index [PVRi]: 2.63 [1.95-2.94] Wood Units·m

conclusionWe observed that even after apparent resolution of ultrasound-defined PH, half of patients had catheterization-defined PH and vasculopathy at 2 years of age. These findings warrant long-term follow-up studies of BPD-associated PH. WHAT IS KNOWN: • Pulmonary hypertension (PH) is associated with increased mortality in infants with bronchopulmonary dysplasia (BPD). Mortality in patients with BPD-associated PH predominantly occurs within the first 6 months of life and most patients who survive beyond 6 months show resolution of PH on echocardiography by 2 to 3 years of age. WHAT IS NEW: • Even after the resolution of echocardiography-derived PH in infants with BPD-associated PH in the mid-term, the majority of such patients have abnormal pulmonary vasculature with PH or mildly elevated pulmonary artery pressure on right heart catheterization (RHC), indicating that echocardiography is insufficient and RHC may be necessary to follow up this population of patients.

Indexed as

Bronchopulmonary DysplasiaCardiac CatheterizationHypertension, PulmonaryChild, PreschoolEchocardiographyFemaleFollow-Up StudiesHumansInfantInfant, NewbornMaleRetrospective StudiesSildenafil CitrateSildenafil CitrateBronchopulmonary dysplasiaCardiac catheterizationExtremely premature infantsPulmonary hypertension

Identifiers

PMID39557732
PMCPMC11573848

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.